Similar results have earlier been reported where significant association was observed between XRCC2 polymorphism rs3218536 with laryngeal and pharyngeal cancer risk40, thyroid cancer risk41, ovarian cancer42, gastric cancer risk43, oral cancer44 and head and neck cancer45. Here, XRCC2 is linked to thyroid gland carcinoma.